Delivery Order SPE2DB25D7067-SPE2DB25FSUQT
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,022.49 firm fixed-price delivery order is for the supply of MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of July 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,405.44, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product, with a period of performance through July 25, 2024. The contract is a Firm Fixed Price Delivery Order and was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen...
- This federal contract award, valued at $1,338.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564881316 - MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product, with a completion date of June 13, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product, with a potential value of $1,019.34 and a completion date of February 8, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,321.76 firm-fixed-price delivery order is for the supply of 4565804905 - MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product. The contract has an ultimate completion date of September 16, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, was awarded this...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,492.07, is for the supply of MUPIROCIN 2% OINT 1S, a pharmaceutical product. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MUPIROCIN 2% OINTMENT 22GM. The contract has a ceiling value of $1,338.24 and is a firm fixed price delivery order. The contract has an ultimate completion date of August 8, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, as the company holds a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MUPIROCIN 2% CREAM 15GM, a pharmaceutical product, with a ceiling value of $1,564.08 and a period of performance through June 13, 2025. The contract is not set-aside and is awarded as a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MUPIROCIN 2% OINTMENT 22GM. The firm fixed price contract has a potential value of $1,144.80 and a completion date of February 22, 2024. Amerisourcebergen Drug Corp provides pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense, through various indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MUPIROCIN 2% CREAM 15GM. The contract has a ceiling value of $1,548.03 and a period of performance through March 13, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSUQTDelivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,002.86, is for the delivery of MUPIROCIN 2% OINTMENT 22GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of March 6, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 3/5/25 |